INVA - Company ID 0001080014
The table below shows Innoviva, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $411.33M | $358.71M | $310.46M | $331.34M | $391.87M | $336.79M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | $307.67M | $296.21M | $246.04M | - | - | - |
| R&D | $30.60M | $13.65M | $33.92M | $41.43M | $576.00K | $1.79M |
| SG&A |
Innoviva, Inc. reported annual revenue of $411.33M for fiscal year 2025. That is up 14.7% from $358.71M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $133.57M (FY 2016) to $411.33M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $113.32M |
| $115.69M |
| $98.23M |
| $63.54M |
| $16.19M |
| $13.88M |
| Operating income | $163.75M | $166.87M | $113.89M | - | $375.10M | $321.12M |
| Income tax | $55.70M | $14.00M | $14.38M | $66.69M | $76.44M | $60.43M |
| Net income | - | - | - | - | - | - |
| EPS (diluted) | $3.30 | $0.36 | $2.20 | $2.37 | $2.87 | $2.02 |